Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1803-2020Class II

ViewRay System: Model No. 10000 and 20000 for radiation treatment. PN11440 MRIdian System Treatment Planning...

Viewray, Inc. / initiated 2019-11-18 / Terminated / root cause: software

Viewray, Inc. began a recall of ViewRay System: Model No. 10000 and 20000 for radiation treatment. PN11440 MRIdian System Treatment Planning and Delivery System (TPDS) software on . FDA classified it as Class II and gives the reason as "Registering dose and structures in the treatment delivery workflow could result in an alignment discrepancy between the imported previously delivered dose and the displayed patient anatomy and structures. The MRIdian...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1803-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Viewray, Inc.
Product
ViewRay System: Model No. 10000 and 20000 for radiation treatment. PN11440 MRIdian System Treatment Planning and Delivery System (TPDS) software
Product code
IYE Accelerator, Linear, Medical
Reason for recall
Registering dose and structures in the treatment delivery workflow could result in an alignment discrepancy between the imported previously delivered dose and the displayed patient anatomy and structures. The MRIdian TPDS software shows this misalignment to the user in the predicted dose-volume histogram (DVH). The misalignment impact may not be obvious to the user. During plan re-optimization the previously delivered dose would be incorrectly accounted for by the software. This may result in unexpectedly higher or lower dose than the intended dose calculated for the subsequent treatment plan. When this occurs in the treatment planning workflow, the registration fails to align the dose with the image and the user is unable to proceed.
Root cause tag
software
FDA root cause
Software design
Action
On 11/18/2019, the firm send an "Urgent Device Correction" letter to customers via email to inform them firm has become aware of an issue impacting the MRIdian System Treatment Planning and Delivery System (TPDS) software. The issue relates to an optional feature related to using previously delivered dose to make a new plan on MRIdian. The firm determined that in some cases dose previously delivered to a patient may not be accurately registered with a daily scan. The firm is instructing its customers to: 1) Do not: Sum previously delivered treatment plans in the treatment delivery workflow as it could result in delivery of a higher or lower dose. 2) Do not: proceed with plan summation if this issue is observed in planning workflow. 3) Do: contact ViewRay Customer Support for assistance when summing plans in the treatment planning workflow. ViewRay is developing a resolution for this issue. You will be contacted by VewRay Customer Support when a software resolution is available. If you have any questions, please do not hesitate to contact ViewRay Customer Support at [email protected] or call +1 855-286-8875.
Quantity in commerce
32
Distribution
Worldwide distribution. US states of MO, WI, CA, FL, MI, NY, MI, IL, and MA. South Korea, Netherlands, Italy, Japan, Germany, UAE, Turkey, France, Israel, Denmark, Switzerland, and United Kingdom. The distributors are assigned to applicable regions. Firm send the Urgent Device Corrections to them and they forwarded them to the sites.
Product codes and lots
Model No.10000 - Serial No's:. 100,104,105,112,113  Model No. 20000 - Serial No's: 101,102,107,108,200,201,203,204,206,207,209,211, 213,214,215,216,217,218,221,223,225,227,228,232,238,240,243, 244,247,250

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1803-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1803-2020Class IITerminatedVoluntary: Firm initiated